SELLAS Life Sciences
SLS
SLS
22 hedge funds and large institutions have $4.28M invested in SELLAS Life Sciences in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
24% less funds holding
Funds holding: 29 → 22 (-7)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
22
Holding in Top 10
–
Calls
$2.77M
Puts
$92K
Top Buyers
| 1 | +$1.79M | |
| 2 | +$58.4K | |
| 3 | +$36.3K | |
| 4 |
EH
Equitable Holdings
New York
|
+$24.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.3K |
Top Sellers
| 1 | -$144K | |
| 2 | -$131K | |
| 3 | -$71.7K | |
| 4 |
VF
Virtu Financial
New York
|
-$43K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$39K |